Recombinant MS4A1 (Rituximab Biosimilar) 抗体
The Human 单克隆 anti-MS4A1 (Rituximab Biosimilar) antibody (ABIN7675649) specifically detects MS4A1 (Rituximab Biosimilar) in FACS, ELISA, BLI, Func 和 SPR.
The antibody is reactive with 人 samples.
产品编号 ABIN7675649
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) 抗体 (ABIN7675649)
抗原
MS4A1 (Rituximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
原理
- Anti-CD20 / MS4A1 Reference Antibody (rituximab)
-
序列
- QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGRGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCARST YYGGDWYFNV WGAGTTVTVS AASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKAE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K,QIVLSQSPAI LSASPGEKVT MTCRASSSVS YIHWFQQKPG SSPKPWIYAT SNLASGVPVR FSGSGSGTSY SLTISRVEAE DAATYYCQQW TSNPPTFGGG TKLEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
-
产品特性
- Anti-CD20 Reference Antibody (rituximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.32 kDa.
-
纯度
- >95 %
-
亚型
- IgG1
-
-
anti-MS4A1 (Rituximab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS 宿主: 兔 Chimeric 10F381 unconjugated Recombinant Antibody
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Therapeutic Agents by Target and Mechanism: CD20 inhibitors(B lymphocyte antigen CD20 inhibitors), ADCC(antibody-dependent cytotoxicity), CD20(targeted cytolysis)
Conditions: Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma Rheumatoid Arthritis (Anti-TNF Refractory) Vasculitis ANCA-associated
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- MS4A1 (Rituximab Biosimilar)
-
别名
- CD20 (Rituximab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Synonyms: Membrane-spanning 4-domains, subfamily A, member 1, MS4A1, B lymphocyte surface antigen B1, Leu-16, Bp35
-
分子量
- 146.32 kDa
-
UniProt
- P11836
抗原
-
You are here:
